• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Making decisions about hormone replacement therapy.

作者信息

Rymer Janice, Wilson Ruth, Ballard Karen

机构信息

Guy's, King's and St Thomas's School of Medicine, Guy's and St Thomas's Hospital Trust, London SE1 7EH.

出版信息

BMJ. 2003 Feb 8;326(7384):322-6. doi: 10.1136/bmj.326.7384.322.

DOI:10.1136/bmj.326.7384.322
PMID:12574048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1125186/
Abstract
摘要

相似文献

1
Making decisions about hormone replacement therapy.关于激素替代疗法的决策
BMJ. 2003 Feb 8;326(7384):322-6. doi: 10.1136/bmj.326.7384.322.
2
Risks and benefits of hormone replacement therapy.激素替代疗法的风险与益处。
Cephalalgia. 2000 Apr;20(3):164-9. doi: 10.1046/j.1468-2982.2000.00037.x.
3
Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.患者摘要。激素疗法预防绝经后女性慢性病：美国预防服务工作组的建议。
Ann Intern Med. 2005 May 17;142(10):I59. doi: 10.7326/0003-4819-142-10-200505170-00004.
4
Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.激素疗法预防绝经后女性慢性病：美国预防服务工作组的建议
Ann Intern Med. 2005 May 17;142(10):855-60.
5
Hormone replacement therapy and cancer: an update.激素替代疗法与癌症：最新进展
Eur J Cancer Prev. 2003 Feb;12(1):3-4. doi: 10.1097/00008469-200302000-00002.
6
For women on hormone therapy, other options may be safer.对于接受激素治疗的女性来说，其他选择可能更安全。
US News World Rep. 2000 Feb 7;128(5):58.
7
Hormone replacement therapy: the right choice for your patient?激素替代疗法：对你的患者来说是正确的选择吗？
J Fam Pract. 2005 May;54(5):428-36.
8
Current perspectives on benefits and risks of hormone replacement therapy.激素替代疗法的益处与风险的当前观点
Am J Obstet Gynecol. 2001 Aug;185(2 Suppl):S13-23. doi: 10.1067/mob.2001.117414.
9
Hormonal replacement therapy in breast cancer.乳腺癌的激素替代疗法。
Ann Oncol. 2002;13 Suppl 4:73-80. doi: 10.1093/annonc/mdf642.
10
[Up-to-date clarification on the menopause hormonal substitutive treatment (HRT) December 2003].[2003年12月更年期激素替代治疗（HRT）的最新阐释]
Gynecol Obstet Fertil. 2004 Jun;32(6):571-5; discussion 569-70. doi: 10.1016/j.gyobfe.2004.05.003.

引用本文的文献

1
Estrogenic activity and toxicity screening of Damnacanthal nanospheres and their metabolites assessed using an bioluminescent yeast assay.使用生物发光酵母试验评估虎刺醛纳米球及其代谢物的雌激素活性和毒性筛选。
Toxicol Rep. 2022 Aug 22;9:1666-1673. doi: 10.1016/j.toxrep.2022.08.009. eCollection 2022.
2
Royal Jelly-A Traditional and Natural Remedy for Postmenopausal Symptoms and Aging-Related Pathologies.蜂王浆——一种传统的天然疗法，可缓解更年期症状和与衰老相关的疾病。
Molecules. 2020 Jul 20;25(14):3291. doi: 10.3390/molecules25143291.
3
Preventive effects of kudzu root on bone loss and cartilage degradation in ovariectomized rats [corrected].葛根对去卵巢大鼠骨质流失和软骨降解的预防作用[校正后]
Am J Transl Res. 2017 Jul 15;9(7):3517-3527. eCollection 2017.
4
The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.台湾使用更年期激素替代疗法的女性患乳腺癌的风险
Int J Environ Res Public Health. 2016 May 11;13(5):482. doi: 10.3390/ijerph13050482.
5
Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms.雌三醇对乳腺癌的雌激素和抗雌激素联合特性可能为治疗更年期症状提供一个安全的治疗窗口。
Oncotarget. 2015 Jul 10;6(19):17621-36. doi: 10.18632/oncotarget.4184.
6
Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells.柚皮素：T47D-KBluc乳腺癌细胞中雌激素受体的部分激动剂。
Int J Clin Exp Med. 2013 Oct 25;6(10):890-9. eCollection 2013.
7
Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo.独眼畸形提取物在体外和体内均表现为雌激素受体α拮抗剂和雌激素受体β激动剂。
PLoS One. 2013 Nov 4;8(11):e79223. doi: 10.1371/journal.pone.0079223. eCollection 2013.
8
Phytoestrogens in postmenopausal indications: A theoretical perspective.绝经后适应症中的植物雌激素：理论视角。
Pharmacogn Rev. 2011 Jan;5(9):41-7. doi: 10.4103/0973-7847.79098.
9
A randomised controlled trial of cognitive-behavioural therapy for women with problematic menopausal hot flushes: MENOS 2 trial protocol.一项针对有问题的更年期热潮红女性的认知行为疗法的随机对照试验：MENOS 2 试验方案。
BMJ Open. 2011 Feb 23;1(1):e000047. doi: 10.1136/bmjopen-2010-000047.
10
Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women.激素替代疗法（HRT）对绝经后妇女牙周状况的影响。
Med Sci Monit. 2011 Apr;17(4):PH23-7. doi: 10.12659/msm.881700.

本文引用的文献

1
Women's use of hormone replacement therapy for disease prevention; results of a community survey.女性使用激素替代疗法预防疾病；一项社区调查的结果
Br J Gen Pract. 2002 Oct;52(483):835-7.
2
Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.连续联合雌激素 - 孕激素替代疗法长期治疗对子宫内膜的影响：随访研究
BMJ. 2002 Aug 3;325(7358):239. doi: 10.1136/bmj.325.7358.239.
3
Failure of estrogen plus progestin therapy for prevention.雌激素加孕激素预防治疗失败。
JAMA. 2002 Jul 17;288(3):366-8. doi: 10.1001/jama.288.3.366.
4
Menopausal hormone replacement therapy and risk of ovarian cancer.更年期激素替代疗法与卵巢癌风险
JAMA. 2002 Jul 17;288(3):334-41. doi: 10.1001/jama.288.3.334.
5
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.健康绝经后妇女使用雌激素加孕激素的风险与益处：妇女健康倡议随机对照试验的主要结果
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
6
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).激素治疗6.8年期间的非心血管疾病转归：心脏和雌激素/孕激素替代研究随访（HERS II）
JAMA. 2002 Jul 3;288(1):58-66. doi: 10.1001/jama.288.1.58.
7
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).激素治疗6.8年期间的心血管疾病转归：心脏和雌激素/孕激素替代研究随访（HERS II）
JAMA. 2002 Jul 3;288(1):49-57. doi: 10.1001/jama.288.1.49.
8
Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.接受口服雌激素替代疗法的绝经后妇女使用宫内10微克和20微克左炔诺孕酮系统：临床、子宫内膜及代谢反应
BJOG. 2002 Feb;109(2):136-44. doi: 10.1111/j.1471-0528.2002.01167.x.
9
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials.激素替代疗法与非椎体骨折的预防：随机试验的荟萃分析
JAMA. 2001 Jun 13;285(22):2891-7. doi: 10.1001/jama.285.22.2891.
10
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups.存在更年期综合征吗？不同种族/族裔群体的更年期状态与症状。
Soc Sci Med. 2001 Feb;52(3):345-56. doi: 10.1016/s0277-9536(00)00147-7.